Resynchronization Reduces Progressive Heart Failure Death By 51% – Study
This article was originally published in The Gray Sheet
Executive Summary
Inclusion of COMPANION trial data in a future meta-analysis could confirm a beneficial effect of cardiac resynchronization on total mortality, Sergio Pinski, MD, Cleveland Clinic Florida, speculates in an editorial published in the Feb. 12 Journal of the American Medical Association
You may also be interested in...
Resync/ICD Combination Eclipsing CRT Pacers, Electrophysiologists Report
A growing number of congestive heart failure patients will receive cardiac resynchronization therapy with ICD backup at the expense of CRT-alone devices, several electrophysiologists predicted May 14
Resync/ICD Combination Eclipsing CRT Pacers, Electrophysiologists Report
A growing number of congestive heart failure patients will receive cardiac resynchronization therapy with ICD backup at the expense of CRT-alone devices, several electrophysiologists predicted May 14
Guidant COMPANION Results Support Contak CD Mortality Benefit
Guidant's Contak CD cardiac resynchronization therapy pacemaker/ICD demonstrated a 40% reduction in all-cause mortality compared with optimum medical therapy, data from the firm-sponsored COMPANION study show